Всероссийская GMP-конференция | Takeda Pharmaceutical
Takeda Pharmaceutical

Official partner

Takeda Pharmaceutical

«Fusion Park» Business-center 2, Bl.1 Usatcheva Str, Moscow 119048

Тел.: +7 (495) 933-55-11                    
E-mail:  russia@takeda.com 


Takeda Pharmaceutical Company Limited (TSE:4502) (NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing better health and a brighter future to patients by translating science into highly-innovative medicines.

Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investment in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to make a difference in people’s lives by advancing the frontier of new treatment options, through our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients, working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com